TMZ 250 Pill - white capsule/oblong, 9mm
Pill with imprint TMZ 250 is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Accord Healthcare Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TMZ 250
Temozolomide
- Imprint
- TMZ 250
- Strength
- 250 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Accord Healthcare Inc.
- National Drug Code (NDC)
- 16729-0051
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
shellac,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
